Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood cancer journal (New York) 2024-09, Vol.14 (1), p.164-5, Article 164
Hauptverfasser:	Hultcrantz, Malin, Hassoun, Hani, Korde, Neha, MacLachlan, Kylee, Mailankody, Sham, Patel, Dhwani, Shah, Urvi A., Tan, Carlyn Rose, Chung, David J., Lahoud, Oscar B., Landau, Heather J., Scordo, Michael, Shah, Gunjan L., Giralt, Sergio A., Pianko, Matthew J., Burge, Miranda, Barnett, Kelly, Salcedo, Meghan, Caple, Julia, Tran, Linh, Blaslov, Jenna, Shekarkhand, Tala, Hamid, Selena, Nemirovsky, David, Derkach, Andriy, Arisa, Oluwatobi, Peer, Cody J., Figg, William D., Usmani, Saad Z., Landgren, Ola, Lesokhin, Alexander M.
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/2779/109 692/308/575 82/16 82/58 Aged Biomedical and Life Sciences Biomedicine Cancer Research Correspondence Diarrhea - chemically induced Female Hematology Humans Lenalidomide - adverse effects Lenalidomide - therapeutic use Male Middle Aged Multiple Myeloma - complications Multiple Myeloma - drug therapy Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!